DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

by Thiago Vidotto, Sarah Nersesian, Charles Graham, D. Robert Siemens, Madhuri Koti
Published 2019-06-01

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer

by Safiya Karim, William J. Mackillop, Kelly Brennan, Yingwei Peng, D. Robert Siemens, Monika K. Krzyzanowska, Christopher M. Booth
Published 2019-10-01

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer

by Safiya Karim, Christopher M. Booth, Kelly Brennan, Yingwei Peng, D. Robert Siemens, Monika K. Krzyzanowska, William J. Mackillop
Published 2019-09-01

Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint

by Stephen Chenard, Chelsea Jackson, Thiago Vidotto, Lina Chen, Céline Hardy, Tamara Jamaspishvilli, David Berman, D. Robert Siemens, Madhuri Koti
Published 2021-07-01

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.

by Alice Yu, Jose Joao Mansure, Shraddha Solanki, D Robert Siemens, Madhuri Koti, Ana B T Dias, Miguel M Burnier, Fadi Brimo, Wassim Kassouf
Published 2018-01-01